These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11873712)

  • 1. Managing schizophrenia during the stable phase: is there consensus among practice guidelines?
    Bhanji NH; Tempier R
    Can J Psychiatry; 2002 Feb; 47(1):76-80. PubMed ID: 11873712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing search strategies for clinical practice guidelines in SUMSearch and Google Scholar and assessing their retrieval performance.
    Haase A; Follmann M; Skipka G; Kirchner H
    BMC Med Res Methodol; 2007 Jun; 7():28. PubMed ID: 17603909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
    Lerner V; Libov I; Kotler M; Strous RD
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical practice guidelines for the treatment of schizophrenia: from theory to practice].
    Delessert D; Pomini V; Grasset F; Baumann P
    Encephale; 2007 Dec; 33(6):902-10. PubMed ID: 18789782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.
    Chan J; Sweeting M
    J Psychopharmacol; 2007 Aug; 21(6):657-64. PubMed ID: 17092976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of clinical practice guidelines for the treatment of schizophrenia].
    Delessert D; Pomini V; Grasset F; Baumann P
    Encephale; 2008 Jan; 34(1):93-100. PubMed ID: 18514156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of atypical antipsychotics for the management of schizophrenia.
    Sprague DA; Loewen PS; Raymond CB
    Ann Pharmacother; 2004 Feb; 38(2):313-9. PubMed ID: 14742771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia.
    Bhanji NH; Chouinard G; Margolese HC
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):87-92. PubMed ID: 15013023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic options for weight management in schizophrenic patients treated with atypical antipsychotics].
    Cordes J; Sinha-Röder A; Kahl KG; Malevani J; Thuenker J; Lange-Asschenfeldt C; Hauner H; Agelink MW; Klimke A
    Fortschr Neurol Psychiatr; 2008 Dec; 76(12):703-14. PubMed ID: 18924059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of different clinical interventions for reducing the burden of schizophrenia in Spain.
    Gutierrez-Recacha P; Chisholm D; Haro JM; Salvador-Carulla L; Ayuso-Mateos JL
    Acta Psychiatr Scand Suppl; 2006; (432):29-38. PubMed ID: 17087813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared decision making in antipsychotic management.
    Mistler LA; Drake RE
    J Psychiatr Pract; 2008 Nov; 14(6):333-44. PubMed ID: 19057236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing suicidality in schizophrenia.
    Mamo DC
    Can J Psychiatry; 2007 Jun; 52(6 Suppl 1):59S-70S. PubMed ID: 17824353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [International comparison of guidelines for the management of benign prostatic hyperplasia: use of a validated generic tool].
    Irani J; Brown C; Van der Meulen J; Emberton M
    Prog Urol; 2004 Feb; 14(1):29-32. PubMed ID: 15098748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment strategies for schizophrenia.
    Lindenmayer JP; Khan A
    Expert Rev Neurother; 2004 Jul; 4(4):705-23. PubMed ID: 15853589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.